February 20, 2020/Neurosciences/Research

Mechanical Thrombectomy for ELVO Strokes: Best to Stop at 3 Attempted Passes?

Study shows MRI infarct growth surges thereafter

20-NEU-062 mechanical-thrombectomy-for-stroke 650×450

In patients undergoing mechanical thrombectomy for emergent large vessel occlusion (ELVO), infarct growth on MRI is significantly associated with both longer procedural time and increasing number of procedural passes attempted, according to a retrospective Cleveland Clinic study presented at the 2020 International Stroke Conference (ISC 2020) this week.


Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“It has been recognized that longer procedure times generally result in more brain damage and worse clinical outcomes in patients with ELVO, but the direct effect on infarct growth has been uncertain, as has the specific contribution of the number of passes attempted to achieve recanalization,” says the study’s senior author, M. Shazam Hussain, MD, Director of Cleveland Clinic’s Cerebrovascular Center.

More than three times is no charm

To shed light on these questions, he and colleagues reviewed consecutive patients presenting with ELVO to Cleveland Clinic’s comprehensive stroke center from January 2016 through December 2018. Only patients with post-procedural MRI (in tandem with pre-procedural MRI, per standard protocol) were included. Procedural times and number of passes attempted were recorded, and infarct volume on MRI was measured using region-of-interest analysis. MRI infarct growth was evaluated using linear regression analysis as a function of procedural duration and number of passes.

Of 173 patients who underwent mechanical thrombectomy over the three-year period, 118 had a post-procedure MRI study and were included in the analysis. Recanalization was successful (TICI score > 2b) in 106 of the 118 patients (89.8%).

Analysis revealed the following:

  • For each additional minute a procedure lasted, MRI infarct growth increased by 0.23 mL (P = 0.04).
  • Mean MRI infarct growth also increased with each procedural pass attempted, from 14.65 mL in cases with one pass (n =67) to 25.67 mL with two passes (n = 26) to 28.68 mL with three passes (n = 17) and to 98.42 mL with four or more passes (n = 8). The association was statistically significant (P = 0.001).

“In addition to finding that infarct growth was time-dependent, we saw that once you go beyond three attempted passes, infarct growth increases dramatically,” says Dr. Hussain. “This suggests that a fourth attempt seems to be a sort of crossing point where risk to the patient may outweigh potential benefit and further attempts at mechanical thrombectomy may not be justified.”


He notes that this finding is consistent with prior studies showing that patient outcomes correlate with time to recanalization, with outcomes starting to notably decline after 60 minutes and dropping precipitously after 90 minutes. “If you’re attempting three passes, you’re probably getting close to that 60-minute mark,” he observes.

Surprises regarding infarct growth and treatment windows

Dr. Hussain’s team presented a related abstract from the same cohort of ELVO patients at ISC 2020, this time focusing on MRI infarct growth according to timing of mechanical thrombectomy.

Of 117 patients from the cohort who met inclusion criteria, 40 (34.2%) underwent early intervention (arterial puncture within 6 hours of ELVO onset) and 77 (65.8%) underwent late intervention (arterial puncture between 6 and 24 hours after ELVO onset).

Analysis showed that patients in the early intervention group demonstrated a trend toward less infarct volume growth versus those in the late intervention group (16.0 ± 42.9 mL vs. 31.4 ± 60.9 mL; P = 0.16). Ratios of pre- to post-intervention infarct volume were significantly different between the early and late interventions groups (P = 0.02), indicating less infarct growth in the early group. “A substantial number of patients in the early window had diffusion-weighted imaging [DWI] reversal,” Dr. Hussain notes.

“These results were a bit surprising, as we had expected patients in the later treatment window to have less infarct growth due to the likelihood that they had better collateral vessels,” he continues. “DWI reversal seems to have contributed substantially to the final infarct volumes in the early time window. While DWI has been thought to represent final infarct, we should reexamine this theory in the early time window.”


All about refining the standard of care

Studies like these represent the evolving research needs around mechanical thrombectomy and ELVO, Dr. Hussain adds. “Now that mechanical thrombectomy is established as a standard of care for ELVO, the relevant research questions include which patients may benefit from this therapy beyond those who fell within the clinical trials’ narrow inclusion criteria,” he says.

“Studies like these analyses of infarct growth help us refine how we perform the procedure and improve patient selection,” he observes. “We will continue to evaluate questions like these to ensure we’re not missing any patients who can benefit from this therapy.”

Related Articles

illustration of an alzheimer brain and a packet of sildenafil pills
March 11, 2024/Neurosciences/Research
Sildenafil as an Alzheimer’s Candidate Drug: Further Support From Insurance Database and Mechanistic Studies

Real-world claims data and tissue culture studies set the stage for randomized clinical testing

June 15, 2022/Neurosciences/Research
MINDS Study Will Assess Lifestyle Interventions for Slowing Brain Pathology in Preclinical Stages

New grant-funded investigation illustrates impact and reach of Cleveland Clinic Brain Study

March 9, 2022/Neurosciences/Research
A Closer Look at the Cleveland Clinic Brain Study

How the new longitudinal investigation could become the Framingham Heart Study of brain health

20-NEU-1959738 powered-exoskeleton-for-gait-training_650x450
October 23, 2020/Neurosciences/Research
Study Signals Potential of Powered Exoskeleton for Gait Training in Multiple Sclerosis

Pilot findings show good patient acceptance and safety, early hints of efficacy

October 21, 2020/Neurosciences/Research
Electronic Screening for Sleep Disorders Among Healthcare Workers Is Feasible – and Sorely Needed

Study finds high prevalence of symptoms, willingness to seek treatment

20-NEU-1946228 neurofilaments_650x450
September 9, 2020/Neurosciences/Research
Serum Neurofilament Light as a Progressive MS Biomarker: Guideposts for the Road Ahead

Panel outlines research priorities around a promising alternative to imaging markers

20-NEU-1951118_Impella-temporary-LVAD_650x450_ (1)
September 4, 2020/Neurosciences/Research
Study Finds Clues to Acute Neurologic Events With Short-Term Impella Cardiac Support

Suspected factors include antithrombotic intensity, time on device, presence of thrombocytopenia

20-NEU-1929179 deep-brain-stimulation-for-TBI_650x450
September 3, 2020/Neurosciences/Research
Could DBS of the Cerebellar Dentate Nucleus Enhance Post-TBI Rehabilitation?

Preclinical studies will assess whether method developed for stroke recovery curbs deficits after brain injury